AbbVie partners with Mission for Alzheimer ’s, Parkinson ' s

AbbVie has agreed to collaborate with Mission Therapeutics to develop deubiquitylating enzymes (DUBs) for the potential treatment of Alzheimer ' s disease and Parkinson ' s disease.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news